"lnp_id","ionizable_lipid","peg_lipid","sterol_lipid","helper_lipid","lipid_molar_ratio","particle_size_nm_std","pdi_std","zeta_potential_mv_std","encapsulation_efficiency_percent_std","loading_capacity_std","target_type","nucleic_acid_sequence","peg_lipid_original","ionizable_lipid_original","helper_lipid_original","sterol_lipid_original","ionizable_lipid_smiles","peg_lipid_smiles","sterol_lipid_smiles","helper_lipid_smiles","synthesis_info","bioactivity_profile","paper_title","paper_authors","paper_doi","paper_journal","paper_year","0","1","2","atlas_row_id","IL_name","HL_name","CHL_name","PEG_name","atlas_ratio","ratio_order","count_atlas","count_lnpdb","lnpdb_row_ids","IL_ratio","HL_ratio","CHL_ratio","PEG_ratio","matched_id"
202,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","213.2","0.4","1.6","52.8","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 1)","C14PEG2K","1-A2-6b","DOPE","cholesterol","NNCC1=CC(=C(O)C(=C1)OC(=O)CC(CC)CCC)OC(=O)CC(CC)CCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"1","A2","6b","Row0","1-A2-6b","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,15,"['Row1' 'Row180' 'Row252' 'Row276' 'Row348' 'Row372' 'Row444' 'Row467'
 'Row539' 'Row563' 'Row635' 'Row659' 'Row731' 'Row755' 'Row827']",35,16,46.5,2.5,"Row1"
203,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","221.9","0.35","4.2","69.7","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 2)","C14PEG2K","2-A2-6b","DOPE","cholesterol","NCCCCNCC1=CC(=C(O)C(=C1)OC(=O)CC(CC)CCC)OC(=O)CC(CC)CCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"2","A2","6b","Row1","2-A2-6b","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,8,"['Row16' 'Row181' 'Row277' 'Row373' 'Row468' 'Row564' 'Row660' 'Row756']",35,16,46.5,2.5,"Row39"
204,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","185.3","0.29","6.2","57.4","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 3)","C14PEG2K","3-A2-6b","DOPE","cholesterol","NC1CCN(CC1)CC2=CC(=C(O)C(=C2)OC(=O)CC(CC)CCC)OC(=O)CC(CC)CCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid (barcoding), 0.1 mg/kg FLuc mRNA (validation); gene_expression_result: Top lung-targeting candidate; biodistribution_result: Lung-specific enrichment; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"3","A2","6b","Row2","3-A2-6b","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,8,"['Row31' 'Row182' 'Row278' 'Row374' 'Row469' 'Row565' 'Row661' 'Row757']",35,16,46.5,2.5,"Row51"
205,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","205.6","0.29","7.1","63","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 4)","C14PEG2K","4-A2-6b","DOPE","cholesterol","NCCN1CCN(CC1)CC2=CC(=C(O)C(=C2)OC(=O)CC(CC)CCC)OC(=O)CC(CC)CCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid (barcoding), 0.1 mg/kg FLuc mRNA (validation); gene_expression_result: Top lung-targeting candidate; biodistribution_result: Lung-specific enrichment; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"4","A2","6b","Row3","4-A2-6b","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,8,"['Row46' 'Row183' 'Row279' 'Row375' 'Row470' 'Row566' 'Row662' 'Row758']",35,16,46.5,2.5,"Row63"
206,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","219.7","0.34","'-5.4","51.5","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 5)","C14PEG2K","11-A2-6b","DOPE","cholesterol","NCCCN(CC1=CC(=C(O)C(=C1)OC(=O)CC(CC)CCC)OC(=O)CC(CC)CCC)CCN","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"11","A2","6b","Row4","11-A2-6b","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,1,"['Row151']",35,16,46.5,2.5,"Row16"
207,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","214.6","0.31","6.6","76.9","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 6)","C14PEG2K","12-A2-6b","DOPE","cholesterol","NCCN(CC1=CC(=C(O)C(=C1)OC(=O)CC(CC)CCC)OC(=O)CC(CC)CCC)CCCN","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"12","A2","6b","Row5","12-A2-6b","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,2,"['Row664' 'Row760']",35,16,46.5,2.5,"Row28"
208,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","182.5","0.25","'-6.2","73.4","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 7)","C14PEG2K","1-A2-7b","DOPE","cholesterol","NNCC1=CC(=C(O)C(=C1)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"1","A2","7b","Row6","1-A2-7b","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,8,"['Row3' 'Row186' 'Row282' 'Row378' 'Row473' 'Row569' 'Row665' 'Row761']",35,16,46.5,2.5,"Row3"
209,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","217","0.41","0.1","77.6","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 8)","C14PEG2K","2-A2-7b","DOPE","cholesterol","NCCCCNCC1=CC(=C(O)C(=C1)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"2","A2","7b","Row7","2-A2-7b","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,8,"['Row18' 'Row187' 'Row283' 'Row379' 'Row474' 'Row570' 'Row666' 'Row762']",35,16,46.5,2.5,"Row41"
210,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","150.1","0.21","4.5","71.6","OTHER:b-DNA:FLuc mRNA weight ratio 10:1, Cas9:sgRNA weight ratio 4:1","mRNA","firefly_luciferase, cre_recombinase, cas9, vegfr2, barcode(dna barcode 9)","C14PEG2K","3-A2-7b","DOPE","cholesterol","NC1CCN(CC1)CC2=CC(=C(O)C(=C2)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice, Ai14 mice, LLC-GFP lung tumor model; administration_route: intravenous (IV); dose: 1.0 mg/kg (barcoding), 0.1 mg/kg FLuc mRNA (validation), 0.3 mg/kg Cre mRNA, 4.0 mg/kg Cas9 mRNA/VEGFR2 sgRNA; gene_expression_result: Top performing LNP for pulmonary delivery - ~90% of total luminescence in lungs, ~60% tdTomato+ endothelial cells; biodistribution_result: Preferential lung accumulation with depletion from liver and spleen; toxicity_profile: Cell viability >85%, minimal in vivo toxicity in tissue histology","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"3","A2","7b","Row8","3-A2-7b","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,8,"['Row33' 'Row188' 'Row284' 'Row380' 'Row475' 'Row571' 'Row667' 'Row763']",35,16,46.5,2.5,"Row53"
211,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","214.9","0.4","1.1","78.3","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 10)","C14PEG2K","4-A2-7b","DOPE","cholesterol","NCCN1CCN(CC1)CC2=CC(=C(O)C(=C2)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid (barcoding), 0.1 mg/kg FLuc mRNA (validation); gene_expression_result: Top lung-targeting candidate; biodistribution_result: Lung-specific enrichment; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"4","A2","7b","Row9","4-A2-7b","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,8,"['Row48' 'Row189' 'Row285' 'Row381' 'Row476' 'Row572' 'Row668' 'Row764']",35,16,46.5,2.5,"Row65"
212,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","145.8","0.15","'-1.6","73","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 11)","C14PEG2K","11-A2-7b","DOPE","cholesterol","NCCCN(CC1=CC(=C(O)C(=C1)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC)CCN","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"11","A2","7b","Row10","11-A2-7b","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,1,"['Row153']",35,16,46.5,2.5,"Row18"
213,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","143.6","0.22","'-0.4","74.5","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 12)","C14PEG2K","12-A2-7b","DOPE","cholesterol","NCCN(CC1=CC(=C(O)C(=C1)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC)CCCN","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"12","A2","7b","Row11","12-A2-7b","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,2,"['Row670' 'Row766']",35,16,46.5,2.5,"Row29"
214,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","210.3","0.21","'-1.3","54.4","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 13)","C14PEG2K","1-A2-7b2","DOPE","cholesterol","NNCC1=CC(=C(O)C(=C1)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"1","A2","7b2","Row12","1-A2-7b2","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,15,"['Row4' 'Row192' 'Row246' 'Row288' 'Row342' 'Row384' 'Row438' 'Row479'
 'Row533' 'Row575' 'Row629' 'Row671' 'Row725' 'Row767' 'Row821']",35,16,46.5,2.5,"Row4"
215,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","182.5","0.24","'-3","59.8","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 14)","C14PEG2K","2-A2-7b2","DOPE","cholesterol","NCCCCNCC1=CC(=C(O)C(=C1)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Spleen-enriched delivery; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"2","A2","7b2","Row13","2-A2-7b2","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,15,"['Row19' 'Row193' 'Row247' 'Row289' 'Row343' 'Row385' 'Row439' 'Row480'
 'Row534' 'Row576' 'Row630' 'Row672' 'Row726' 'Row768' 'Row822']",35,16,46.5,2.5,"Row42"
216,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","206.3","0.31","1.9","51.3","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 15)","C14PEG2K","3-A2-7b2","DOPE","cholesterol","NC1CCN(CC1)CC2=CC(=C(O)C(=C2)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"3","A2","7b2","Row14","3-A2-7b2","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,15,"['Row34' 'Row194' 'Row248' 'Row290' 'Row344' 'Row386' 'Row440' 'Row481'
 'Row535' 'Row577' 'Row631' 'Row673' 'Row727' 'Row769' 'Row823']",35,16,46.5,2.5,"Row54"
217,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","221.1","0.25","'-8.4","75.1","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 16)","C14PEG2K","4-A2-7b2","DOPE","cholesterol","NCCN1CCN(CC1)CC2=CC(=C(O)C(=C2)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"4","A2","7b2","Row15","4-A2-7b2","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,15,"['Row49' 'Row195' 'Row249' 'Row291' 'Row345' 'Row387' 'Row441' 'Row482'
 'Row536' 'Row578' 'Row632' 'Row674' 'Row728' 'Row770' 'Row824']",35,16,46.5,2.5,"Row66"
218,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","212.3","0.27","'-0.7","54.8","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 17)","C14PEG2K","11-A2-7b2","DOPE","cholesterol","NCCCN(CC1=CC(=C(O)C(=C1)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC)CCN","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"11","A2","7b2","Row16","11-A2-7b2","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,1,"['Row154']",35,16,46.5,2.5,"Row19"
219,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","173.2","0.21","4.3","85.6","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 18)","C14PEG2K","12-A2-7b2","DOPE","cholesterol","NCCN(CC1=CC(=C(O)C(=C1)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC)CCCN","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"12","A2","7b2","Row17","12-A2-7b2","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,4,"['Row676' 'Row730' 'Row772' 'Row826']",35,16,46.5,2.5,"Row30"
220,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","136.4","0.23","2.8","84.3","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 19)","C14PEG2K","1-A2-8b","DOPE","cholesterol","NNCC1=CC(=C(O)C(=C1)OC(=O)CC(CC)CCCCC)OC(=O)CC(CC)CCCCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"1","A2","8b","Row18","1-A2-8b","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,8,"['Row6' 'Row198' 'Row294' 'Row390' 'Row485' 'Row581' 'Row677' 'Row773']",35,16,46.5,2.5,"Row5"
221,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","138.3","0.21","'-0.8","75.1","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 20)","C14PEG2K","2-A2-8b","DOPE","cholesterol","NCCCCNCC1=CC(=C(O)C(=C1)OC(=O)CC(CC)CCCCC)OC(=O)CC(CC)CCCCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid, 0.25 mg/kg FLuc mRNA (validation); gene_expression_result: Liver-targeting LNP; biodistribution_result: Liver-enriched delivery; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"2","A2","8b","Row19","2-A2-8b","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,8,"['Row21' 'Row199' 'Row295' 'Row391' 'Row486' 'Row582' 'Row678' 'Row774']",35,16,46.5,2.5,"Row43"
222,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","116.2","0.27","'-3.6","85.7","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 21)","C14PEG2K","3-A2-8b","DOPE","cholesterol","NC1CCN(CC1)CC2=CC(=C(O)C(=C2)OC(=O)CC(CC)CCCCC)OC(=O)CC(CC)CCCCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"3","A2","8b","Row20","3-A2-8b","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,8,"['Row36' 'Row200' 'Row296' 'Row392' 'Row487' 'Row583' 'Row679' 'Row775']",35,16,46.5,2.5,"Row55"
223,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","110.5","0.22","2.6","77.3","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 22)","C14PEG2K","4-A2-8b","DOPE","cholesterol","NCCN1CCN(CC1)CC2=CC(=C(O)C(=C2)OC(=O)CC(CC)CCCCC)OC(=O)CC(CC)CCCCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"4","A2","8b","Row21","4-A2-8b","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,8,"['Row51' 'Row201' 'Row297' 'Row393' 'Row488' 'Row584' 'Row680' 'Row776']",35,16,46.5,2.5,"Row67"
224,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","149.1","0.25","'-0.1","71.9","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 23)","C14PEG2K","11-A2-8b","DOPE","cholesterol","NCCCN(CC1=CC(=C(O)C(=C1)OC(=O)CC(CC)CCCCC)OC(=O)CC(CC)CCCCC)CCN","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"11","A2","8b","Row22","11-A2-8b","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,1,"['Row156']",35,16,46.5,2.5,"Row20"
225,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","151.5","0.23","3.1","87.1","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 24)","C14PEG2K","12-A2-8b","DOPE","cholesterol","NCCN(CC1=CC(=C(O)C(=C1)OC(=O)CC(CC)CCCCC)OC(=O)CC(CC)CCCCC)CCCN","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; gene_expression_result: Greatest enrichment in lungs but also enriched in liver and spleen; biodistribution_result: High lung enrichment but not lung-specific; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"12","A2","8b","Row23","12-A2-8b","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,2,"['Row682' 'Row778']",35,16,46.5,2.5,"Row31"
227,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","164.2","0.18","'-1.6","48.1","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 25)","C14PEG2K","1-A2-9b","DOPE","cholesterol","NNCC1=CC(=C(O)C(=C1)OC(=O)CC(CCCCCC)CC)OC(=O)CC(CCCCCC)CC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"1","A2","9b","Row25","1-A2-9b","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,8,"['Row8' 'Row204' 'Row300' 'Row396' 'Row491' 'Row587' 'Row683' 'Row779']",35,16,46.5,2.5,"Row6"
228,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","186.2","0.26","5.8","66.2","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 26)","C14PEG2K","2-A2-9b","DOPE","cholesterol","NCCCCNCC1=CC(=C(O)C(=C1)OC(=O)CC(CCCCCC)CC)OC(=O)CC(CCCCCC)CC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"2","A2","9b","Row26","2-A2-9b","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,8,"['Row23' 'Row205' 'Row301' 'Row397' 'Row492' 'Row588' 'Row684' 'Row780']",35,16,46.5,2.5,"Row44"
229,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","169.9","0.2","'-8.8","54.9","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 27)","C14PEG2K","3-A2-9b","DOPE","cholesterol","NC1CCN(CC1)CC2=CC(=C(O)C(=C2)OC(=O)CC(CCCCCC)CC)OC(=O)CC(CCCCCC)CC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"3","A2","9b","Row27","3-A2-9b","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,8,"['Row38' 'Row206' 'Row302' 'Row398' 'Row493' 'Row589' 'Row685' 'Row781']",35,16,46.5,2.5,"Row56"
230,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","172.1","0.23","5.2","50.9","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 28)","C14PEG2K","4-A2-9b","DOPE","cholesterol","NCCN1CCN(CC1)CC2=CC(=C(O)C(=C2)OC(=O)CC(CCCCCC)CC)OC(=O)CC(CCCCCC)CC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"4","A2","9b","Row28","4-A2-9b","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,8,"['Row53' 'Row207' 'Row303' 'Row399' 'Row494' 'Row590' 'Row686' 'Row782']",35,16,46.5,2.5,"Row68"
231,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","153.1","0.18","2.9","48.7","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 29)","C14PEG2K","11-A2-9b","DOPE","cholesterol","NCCCN(CC1=CC(=C(O)C(=C1)OC(=O)CC(CCCCCC)CC)OC(=O)CC(CCCCCC)CC)CCN","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"11","A2","9b","Row29","11-A2-9b","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,1,"['Row158']",35,16,46.5,2.5,"Row21"
232,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","135.1","0.14","9.2","69.4","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 30)","C14PEG2K","12-A2-9b","DOPE","cholesterol","NCCN(CC1=CC(=C(O)C(=C1)OC(=O)CC(CCCCCC)CC)OC(=O)CC(CCCCCC)CC)CCCN","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"12","A2","9b","Row30","12-A2-9b","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,1,"['Row820']",35,16,46.5,2.5,"Row32"
233,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","167.1","0.23","12.7","54.9","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 31)","C14PEG2K","1-A2-9b2","DOPE","cholesterol","NNCC1=CC(=C(O)C(=C1)OC(=O)CCC(CC)CCCCCC)OC(=O)CCC(CC)CCCCCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"1","A2","9b2","Row31","1-A2-9b2","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,8,"['Row9' 'Row210' 'Row306' 'Row402' 'Row497' 'Row593' 'Row689' 'Row785']",35,16,46.5,2.5,"Row7"
234,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","164.2","0.19","'-6.4","73.2","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 32)","C14PEG2K","2-A2-9b2","DOPE","cholesterol","NCCCCNCC1=CC(=C(O)C(=C1)OC(=O)CCC(CC)CCCCCC)OC(=O)CCC(CC)CCCCCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"2","A2","9b2","Row32","2-A2-9b2","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,8,"['Row24' 'Row211' 'Row307' 'Row403' 'Row498' 'Row594' 'Row690' 'Row786']",35,16,46.5,2.5,"Row45"
235,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","157.1","0.17","'-10.7","53.1","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 33)","C14PEG2K","3-A2-9b2","DOPE","cholesterol","NC1CCN(CC1)CC2=CC(=C(O)C(=C2)OC(=O)CCC(CC)CCCCCC)OC(=O)CCC(CC)CCCCCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"3","A2","9b2","Row33","3-A2-9b2","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,8,"['Row39' 'Row212' 'Row308' 'Row404' 'Row499' 'Row595' 'Row691' 'Row787']",35,16,46.5,2.5,"Row57"
236,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","171.9","0.1","14.7","64.1","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 34)","C14PEG2K","4-A2-9b2","DOPE","cholesterol","NCCN1CCN(CC1)CC2=CC(=C(O)C(=C2)OC(=O)CCC(CC)CCCCCC)OC(=O)CCC(CC)CCCCCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"4","A2","9b2","Row34","4-A2-9b2","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,8,"['Row54' 'Row213' 'Row309' 'Row405' 'Row500' 'Row596' 'Row692' 'Row788']",35,16,46.5,2.5,"Row69"
237,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","166.8","0.18","10.4","57.3","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 35)","C14PEG2K","11-A2-9b2","DOPE","cholesterol","NCCCN(CC1=CC(=C(O)C(=C1)OC(=O)CCC(CC)CCCCCC)OC(=O)CCC(CC)CCCCCC)CCN","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"11","A2","9b2","Row35","11-A2-9b2","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,1,"['Row159']",35,16,46.5,2.5,"Row22"
238,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","160.8","0.16","'-4.3","58.4","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 36)","C14PEG2K","12-A2-9b2","DOPE","cholesterol","NCCN(CC1=CC(=C(O)C(=C1)OC(=O)CCC(CC)CCCCCC)OC(=O)CCC(CC)CCCCCC)CCCN","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"12","A2","9b2","Row36","12-A2-9b2","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,1,"['Row839']",35,16,46.5,2.5,"Row33"
239,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","150.3","0.19","'-9.6","39.2","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 37)","C14PEG2K","1-A3-6b","DOPE","cholesterol","NNCC1=CC(=C(OC(=O)CC(CC)CCC)C(=C1)OC(=O)CC(CC)CCC)OC(=O)CC(CC)CCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"1","A3","6b","Row37","1-A3-6b","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,8,"['Row10' 'Row216' 'Row312' 'Row408' 'Row503' 'Row599' 'Row695' 'Row791']",35,16,46.5,2.5,"Row8"
240,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","154.9","0.13","1.2","42.5","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 38)","C14PEG2K","2-A3-6b","DOPE","cholesterol","NCCCCNCC1=CC(=C(OC(=O)CC(CC)CCC)C(=C1)OC(=O)CC(CC)CCC)OC(=O)CC(CC)CCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"2","A3","6b","Row38","2-A3-6b","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,8,"['Row25' 'Row217' 'Row313' 'Row409' 'Row504' 'Row600' 'Row696' 'Row792']",35,16,46.5,2.5,"Row46"
241,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","159.3","0.14","12.6","48.8","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 39)","C14PEG2K","3-A3-6b","DOPE","cholesterol","NC1CCN(CC1)CC2=CC(=C(OC(=O)CC(CC)CCC)C(=C2)OC(=O)CC(CC)CCC)OC(=O)CC(CC)CCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"3","A3","6b","Row39","3-A3-6b","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,8,"['Row40' 'Row218' 'Row314' 'Row410' 'Row505' 'Row601' 'Row697' 'Row793']",35,16,46.5,2.5,"Row58"
242,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","151.4","0.22","6.9","49.6","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 40)","C14PEG2K","4-A3-6b","DOPE","cholesterol","NCCN1CCN(CC1)CC2=CC(=C(OC(=O)CC(CC)CCC)C(=C2)OC(=O)CC(CC)CCC)OC(=O)CC(CC)CCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"4","A3","6b","Row40","4-A3-6b","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,8,"['Row55' 'Row219' 'Row315' 'Row411' 'Row506' 'Row602' 'Row698' 'Row794']",35,16,46.5,2.5,"Row70"
243,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","135.4","0.12","9.2","46.8","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 41)","C14PEG2K","11-A3-6b","DOPE","cholesterol","NCCCN(CC1=CC(=C(OC(=O)CC(CC)CCC)C(=C1)OC(=O)CC(CC)CCC)OC(=O)CC(CC)CCC)CCN","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"11","A3","6b","Row41","11-A3-6b","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,1,"['Row160']",35,16,46.5,2.5,"Row23"
244,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","156.2","0.16","'-3.6","37","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 42)","C14PEG2K","12-A3-6b","DOPE","cholesterol","NCCN(CC1=CC(=C(OC(=O)CC(CC)CCC)C(=C1)OC(=O)CC(CC)CCC)OC(=O)CC(CC)CCC)CCCN","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"12","A3","6b","Row42","12-A3-6b","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,2,"['Row700' 'Row796']",35,16,46.5,2.5,"Row34"
245,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","158.1","0.15","6.7","53.4","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 43)","C14PEG2K","1-A3-7b","DOPE","cholesterol","NNCC1=CC(=C(OC(=O)CC(CC)CCCC)C(=C1)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"1","A3","7b","Row43","1-A3-7b","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,8,"['Row11' 'Row222' 'Row318' 'Row414' 'Row509' 'Row605' 'Row701' 'Row797']",35,16,46.5,2.5,"Row9"
246,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","176","0.16","7.4","77.9","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 44)","C14PEG2K","2-A3-7b","DOPE","cholesterol","NCCCCNCC1=CC(=C(OC(=O)CC(CC)CCCC)C(=C1)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"2","A3","7b","Row44","2-A3-7b","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,8,"['Row26' 'Row223' 'Row319' 'Row415' 'Row510' 'Row606' 'Row702' 'Row798']",35,16,46.5,2.5,"Row47"
247,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","167.4","0.16","8.9","60.2","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 45)","C14PEG2K","3-A3-7b","DOPE","cholesterol","NC1CCN(CC1)CC2=CC(=C(OC(=O)CC(CC)CCCC)C(=C2)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"3","A3","7b","Row45","3-A3-7b","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,8,"['Row41' 'Row224' 'Row320' 'Row416' 'Row511' 'Row607' 'Row703' 'Row799']",35,16,46.5,2.5,"Row59"
248,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","159.8","0.1","2.4","66.7","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 46)","C14PEG2K","4-A3-7b","DOPE","cholesterol","NCCN1CCN(CC1)CC2=CC(=C(OC(=O)CC(CC)CCCC)C(=C2)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"4","A3","7b","Row46","4-A3-7b","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,8,"['Row56' 'Row225' 'Row321' 'Row417' 'Row512' 'Row608' 'Row704' 'Row800']",35,16,46.5,2.5,"Row71"
249,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","143.2","0.14","7","45.5","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 47)","C14PEG2K","11-A3-7b","DOPE","cholesterol","NCCCN(CC1=CC(=C(OC(=O)CC(CC)CCCC)C(=C1)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC)CCN","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"11","A3","7b","Row47","11-A3-7b","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,1,"['Row161']",35,16,46.5,2.5,"Row24"
250,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","174.6","0.14","8.8","63.3","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 48)","C14PEG2K","12-A3-7b","DOPE","cholesterol","NCCN(CC1=CC(=C(OC(=O)CC(CC)CCCC)C(=C1)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC)CCCN","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"12","A3","7b","Row48","12-A3-7b","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,5,"['Row651' 'Row706' 'Row747' 'Row802' 'Row843']",35,16,46.5,2.5,"Row35"
251,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","175.2 ¡¾ 3.0","0.26 ¡¾ 0.10","1.4 ¡¾ 2.5","78.5 ¡¾ 4.1","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 49)","C14PEG2K","1-A3-7b2","DOPE","cholesterol","NNCC1=CC(=C(OC(=O)CC(CC)CCCC)C(=C1)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"1","A3","7b2","Row49","1-A3-7b2","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,8,"['Row12' 'Row228' 'Row324' 'Row420' 'Row515' 'Row611' 'Row707' 'Row803']",35,16,46.5,2.5,"Row10"
252,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","163.1 ¡¾ 6.5","0.19 ¡¾ 0.05","'-7.2 ¡¾ 2.9","78.8 ¡¾ 2.7","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 50)","C14PEG2K","2-A3-7b2","DOPE","cholesterol","NCCCCNCC1=CC(=C(OC(=O)CC(CC)CCCC)C(=C1)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"2","A3","7b2","Row50","2-A3-7b2","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,8,"['Row27' 'Row229' 'Row325' 'Row421' 'Row516' 'Row612' 'Row708' 'Row804']",35,16,46.5,2.5,"Row48"
253,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","162.2 ¡¾ 2.7","0.23 ¡¾ 0.06","6.2 ¡¾ 1.6","79.3 ¡¾ 1.7","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 51)","C14PEG2K","3-A3-7b2","DOPE","cholesterol","NC1CCN(CC1)CC2=CC(=C(OC(=O)CC(CC)CCCC)C(=C2)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"3","A3","7b2","Row51","3-A3-7b2","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,8,"['Row42' 'Row230' 'Row326' 'Row422' 'Row517' 'Row613' 'Row709' 'Row805']",35,16,46.5,2.5,"Row60"
254,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","159.9 ¡¾ 3.6","0.10 ¡¾ 0.06","5.2 ¡¾ 2.4","77.9 ¡¾ 6.2","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 52)","C14PEG2K","4-A3-7b2","DOPE","cholesterol","NCCN1CCN(CC1)CC2=CC(=C(OC(=O)CC(CC)CCCC)C(=C2)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"4","A3","7b2","Row52","4-A3-7b2","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,8,"['Row57' 'Row231' 'Row327' 'Row423' 'Row518' 'Row614' 'Row710' 'Row806']",35,16,46.5,2.5,"Row72"
255,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","162.3 ¡¾ 3.0","0.13 ¡¾ 0.02","6.4 ¡¾ 1.2","79.0 ¡¾ 3.7","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 53)","C14PEG2K","11-A3-7b2","DOPE","cholesterol","NCCCN(CC1=CC(=C(OC(=O)CC(CC)CCCC)C(=C1)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC)CCN","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"11","A3","7b2","Row53","11-A3-7b2","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,1,"['Row162']",35,16,46.5,2.5,"Row25"
256,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","151.7 ¡¾ 4.9","0.21 ¡¾ 0.03","'-0.5 ¡¾ 1.3","79.4 ¡¾ 3.1","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 54)","C14PEG2K","12-A3-7b2","DOPE","cholesterol","NCCN(CC1=CC(=C(OC(=O)CC(CC)CCCC)C(=C1)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC)CCCN","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"12","A3","7b2","Row54","12-A3-7b2","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,2,"['Row712' 'Row808']",35,16,46.5,2.5,"Row36"
257,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","155.1 ¡¾ 5.2","0.16 ¡¾ 0.03","'-8.2 ¡¾ 1.4","57.8 ¡¾ 2.7","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 55)","C14PEG2K","1-A3-8b","DOPE","cholesterol","NNCC1=CC(=C(OC(=O)CC(CC)CCCCC)C(=C1)OC(=O)CC(CC)CCCCC)OC(=O)CC(CC)CCCCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"1","A3","8b","Row55","1-A3-8b","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,8,"['Row13' 'Row234' 'Row330' 'Row426' 'Row521' 'Row617' 'Row713' 'Row809']",35,16,46.5,2.5,"Row11"
258,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","151.7 ¡¾ 3.2","0.25 ¡¾ 0.08","1.4 ¡¾ 0.9","63.9 ¡¾ 3.4","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 56)","C14PEG2K","2-A3-8b","DOPE","cholesterol","NCCCCNCC1=CC(=C(OC(=O)CC(CC)CCCCC)C(=C1)OC(=O)CC(CC)CCCCC)OC(=O)CC(CC)CCCCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; gene_expression_result: Greatest enrichment in lungs but also enriched in liver and spleen; biodistribution_result: High lung enrichment but not lung-specific; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"2","A3","8b","Row56","2-A3-8b","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,8,"['Row28' 'Row235' 'Row331' 'Row427' 'Row522' 'Row618' 'Row714' 'Row810']",35,16,46.5,2.5,"Row49"
259,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","162.3 ¡¾ 2.6","0.25 ¡¾ 0.10","4.7 ¡¾ 1.7","41.8 ¡¾ 2.2","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 57)","C14PEG2K","3-A3-8b","DOPE","cholesterol","NC1CCN(CC1)CC2=CC(=C(OC(=O)CC(CC)CCCCC)C(=C2)OC(=O)CC(CC)CCCCC)OC(=O)CC(CC)CCCCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"3","A3","8b","Row57","3-A3-8b","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,8,"['Row43' 'Row236' 'Row332' 'Row428' 'Row523' 'Row619' 'Row715' 'Row811']",35,16,46.5,2.5,"Row61"
260,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","140.8 ¡¾ 4.5","0.16 ¡¾ 0.07","8.6 ¡¾ 0.9","40.6 ¡¾ 3.4","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 58)","C14PEG2K","4-A3-8b","DOPE","cholesterol","NCCN1CCN(CC1)CC2=CC(=C(OC(=O)CC(CC)CCCCC)C(=C2)OC(=O)CC(CC)CCCCC)OC(=O)CC(CC)CCCCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"4","A3","8b","Row58","4-A3-8b","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,8,"['Row58' 'Row237' 'Row333' 'Row429' 'Row524' 'Row620' 'Row716' 'Row812']",35,16,46.5,2.5,"Row73"
261,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","173.5 ¡¾ 5.8","0.20 ¡¾ 0.05","'-5.6 ¡¾ 6.3","57.6 ¡¾ 3.0","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 59)","C14PEG2K","11-A3-8b","DOPE","cholesterol","NCCCN(CC1=CC(=C(OC(=O)CC(CC)CCCCC)C(=C1)OC(=O)CC(CC)CCCCC)OC(=O)CC(CC)CCCCC)CCN","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"11","A3","8b","Row59","11-A3-8b","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,1,"['Row163']",35,16,46.5,2.5,"Row26"
262,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","146.7 ¡¾ 6.5","0.25 ¡¾ 0.06","5.1 ¡¾ 2.7","59.2 ¡¾ 2.9","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 60)","C14PEG2K","12-A3-8b","DOPE","cholesterol","NCCN(CC1=CC(=C(OC(=O)CC(CC)CCCCC)C(=C1)OC(=O)CC(CC)CCCCC)OC(=O)CC(CC)CCCCC)CCCN","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"12","A3","8b","Row60","12-A3-8b","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,2,"['Row718' 'Row814']",35,16,46.5,2.5,"Row37"
263,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","161.7 ¡¾ 6.8","0.22 ¡¾ 0.06","7.9 ¡¾ 1.9","46.9 ¡¾ 2.5","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 61)","C14PEG2K","1-A3-9b2","DOPE","cholesterol","NNCC1=CC(=C(OC(=O)CCC(CC)CCCCCC)C(=C1)OC(=O)CCC(CC)CCCCCC)OC(=O)CCC(CC)CCCCCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"1","A3","9b2","Row61","1-A3-9b2","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,197,"['Row14' 'Row165' 'Row166' 'Row167' 'Row168' 'Row169' 'Row170' 'Row171'
 'Row172' 'Row173' 'Row174' 'Row175' 'Row176' 'Row177' 'Row178' 'Row179'
 'Row184' 'Row185' 'Row190' 'Row191' 'Row196' 'Row197' 'Row202' 'Row203'
 'Row208' 'Row209' 'Row214' 'Row215' 'Row220' 'Row221' 'Row226' 'Row227'
 'Row232' 'Row233' 'Row238' 'Row239' 'Row240' 'Row244' 'Row245' 'Row250'
 'Row251' 'Row263' 'Row264' 'Row266' 'Row268' 'Row275' 'Row280' 'Row281'
 'Row286' 'Row287' 'Row292' 'Row293' 'Row298' 'Row299' 'Row304' 'Row305'
 'Row310' 'Row311' 'Row316' 'Row317' 'Row322' 'Row323' 'Row328' 'Row329'
 'Row334' 'Row335' 'Row336' 'Row340' 'Row341' 'Row346' 'Row347' 'Row359'
 'Row360' 'Row362' 'Row364' 'Row371' 'Row376' 'Row377' 'Row382' 'Row383'
 'Row388' 'Row389' 'Row394' 'Row395' 'Row400' 'Row401' 'Row406' 'Row407'
 'Row412' 'Row413' 'Row418' 'Row419' 'Row424' 'Row425' 'Row430' 'Row431'
 'Row432' 'Row436' 'Row437' 'Row442' 'Row443' 'Row455' 'Row456' 'Row458'
 'Row460' 'Row466' 'Row471' 'Row472' 'Row477' 'Row478' 'Row483' 'Row484'
 'Row489' 'Row490' 'Row495' 'Row496' 'Row501' 'Row502' 'Row507' 'Row508'
 'Row513' 'Row514' 'Row519' 'Row520' 'Row525' 'Row526' 'Row527' 'Row531'
 'Row532' 'Row537' 'Row538' 'Row550' 'Row551' 'Row553' 'Row555' 'Row562'
 'Row567' 'Row568' 'Row573' 'Row574' 'Row579' 'Row580' 'Row585' 'Row586'
 'Row591' 'Row592' 'Row597' 'Row598' 'Row603' 'Row604' 'Row609' 'Row610'
 'Row615' 'Row616' 'Row621' 'Row622' 'Row623' 'Row627' 'Row628' 'Row633'
 'Row634' 'Row646' 'Row647' 'Row649' 'Row658' 'Row663' 'Row669' 'Row675'
 'Row681' 'Row687' 'Row693' 'Row699' 'Row705' 'Row711' 'Row717' 'Row719'
 'Row723' 'Row729' 'Row742' 'Row745' 'Row754' 'Row759' 'Row765' 'Row771'
 'Row777' 'Row783' 'Row789' 'Row795' 'Row801' 'Row807' 'Row813' 'Row815'
 'Row819' 'Row825' 'Row838' 'Row841' 'Row850']",35,16,46.5,2.5,"Row12"
264,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","168.9 ¡¾ 3.1","0.18 ¡¾ 0.02","'-2.4 ¡¾ 0.9","65.6 ¡¾ 3.0","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 62)","C14PEG2K","2-A3-9b2","DOPE","cholesterol","NCCCCNCC1=CC(=C(OC(=O)CCC(CC)CCCCCC)C(=C1)OC(=O)CCC(CC)CCCCCC)OC(=O)CCC(CC)CCCCCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"2","A3","9b2","Row62","2-A3-9b2","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,8,"['Row29' 'Row241' 'Row337' 'Row433' 'Row528' 'Row624' 'Row720' 'Row816']",35,16,46.5,2.5,"Row50"
265,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","169.2 ¡¾ 5.5","0.22 ¡¾ 0.07","2.6 ¡¾ 1.8","54.3 ¡¾ 2.9","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 63)","C14PEG2K","3-A3-9b2","DOPE","cholesterol","NC1CCN(CC1)CC2=CC(=C(OC(=O)CCC(CC)CCCCCC)C(=C2)OC(=O)CCC(CC)CCCCCC)OC(=O)CCC(CC)CCCCCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"3","A3","9b2","Row63","3-A3-9b2","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,8,"['Row44' 'Row242' 'Row338' 'Row434' 'Row529' 'Row625' 'Row721' 'Row817']",35,16,46.5,2.5,"Row62"
266,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","184.3 ¡¾ 6.4","0.12 ¡¾ 0.04","5.8 ¡¾ 3.4","48.0 ¡¾ 2.7","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 64)","C14PEG2K","4-A3-9b2","DOPE","cholesterol","NCCN1CCN(CC1)CC2=CC(=C(OC(=O)CCC(CC)CCCCCC)C(=C2)OC(=O)CCC(CC)CCCCCC)OC(=O)CCC(CC)CCCCCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"4","A3","9b2","Row64","4-A3-9b2","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,8,"['Row59' 'Row243' 'Row339' 'Row435' 'Row530' 'Row626' 'Row722' 'Row818']",35,16,46.5,2.5,"Row74"
267,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","173.9 ¡¾ 5.3","0.12 ¡¾ 0.03","'-0.9 ¡¾ 1.2","47.1 ¡¾ 5.7","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 65)","C14PEG2K","11-A3-9b2","DOPE","cholesterol","NCCCN(CC1=CC(=C(OC(=O)CCC(CC)CCCCCC)C(=C1)OC(=O)CCC(CC)CCCCCC)OC(=O)CCC(CC)CCCCCC)CCN","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"11","A3","9b2","Row65","11-A3-9b2","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,1,"['Row164']",35,16,46.5,2.5,"Row27"
268,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","154.3 ¡¾ 4.8","0.13 ¡¾ 0.07","8.7 ¡¾ 1.4","37.2 ¡¾ 3.6","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 66)","C14PEG2K","12-A3-9b2","DOPE","cholesterol","NCCN(CC1=CC(=C(OC(=O)CCC(CC)CCCCCC)C(=C1)OC(=O)CCC(CC)CCCCCC)OC(=O)CCC(CC)CCCCCC)CCCN","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"12","A3","9b2","Row66","12-A3-9b2","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,6,"['Row688' 'Row694' 'Row724' 'Row743' 'Row784' 'Row790']",35,16,46.5,2.5,"Row38"
269,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","192.2 ¡¾ 5.1","0.08 ¡¾ 0.05","'-1.2 ¡¾ 0.8","77.8 ¡¾ 3.5","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 67)","C14PEG2K","1-A2-7","DOPE","cholesterol","NNCC1=CC(=C(O)C(=C1)OC(=O)CCCCCCCC)OC(=O)CCCCCCCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"1","A2","7","Row67","1-A2-7","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,1,"['Row2']",35,16,46.5,2.5,"Row2"
270,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","178.9 ¡¾ 3.7","0.18 ¡¾ 0.04","1.4 ¡¾ 1.9","84.0 ¡¾ 6.1","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 68)","C14PEG2K","2-A2-7","DOPE","cholesterol","NCCCCNCC1=CC(=C(O)C(=C1)OC(=O)CCCCCCCC)OC(=O)CCCCCCCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"2","A2","7","Row68","2-A2-7","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,1,"['Row17']",35,16,46.5,2.5,"Row40"
271,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","193.7 ¡¾ 5.0","0.07 ¡¾ 0.05","4.4 ¡¾ 4.0","74.6 ¡¾ 3.5","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 69)","C14PEG2K","3-A2-7","DOPE","cholesterol","NC1CCN(CC1)CC2=CC(=C(O)C(=C2)OC(=O)CCCCCCCC)OC(=O)CCCCCCCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"3","A2","7","Row69","3-A2-7","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,1,"['Row32']",35,16,46.5,2.5,"Row52"
272,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","181.2 ¡¾ 3.9","0.10 ¡¾ 0.05","1.5 ¡¾ 7.5","82.2 ¡¾ 4.3","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 70)","C14PEG2K","4-A2-7","DOPE","cholesterol","NCCN1CCN(CC1)CC2=CC(=C(O)C(=C2)OC(=O)CCCCCCCC)OC(=O)CCCCCCCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"4","A2","7","Row70","4-A2-7","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,1,"['Row47']",35,16,46.5,2.5,"Row64"
273,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","195.1 ¡¾ 6.3","0.12 ¡¾ 0.04","8.6 ¡¾ 15.5","81.0 ¡¾ 4.8","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 71)","C14PEG2K","11-A2-7","DOPE","cholesterol","NCCCN(CC1=CC(=C(O)C(=C1)OC(=O)CCCCCCCC)OC(=O)CCCCCCCC)CCN","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"11","A2","7","Row71","11-A2-7","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,1,"['Row152']",35,16,46.5,2.5,"Row17"
275,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","203.4 ¡¾ 4.9","0.18 ¡¾ 0.09","3.8 ¡¾ 1.4","85.2 ¡¾ 4.9","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 73)","C14PEG2K","1-A2-6","DOPE","cholesterol","NNCC1=CC(=C(O)C(=C1)OC(=O)CCCCCC)OC(=O)CCCCCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; gene_expression_result: Spleen-enriched delivery; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"1","A2","6","Row73","1-A2-6","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,1,"['Row0']",35,16,46.5,2.5,"Row0"
276,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","174.0 ¡¾ 5.5","0.23 ¡¾ 0.05","7.9 ¡¾ 1.3","81.2 ¡¾ 2.7","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 74)","C14PEG2K","5-A2-6b","DOPE","cholesterol","CN(C)CCNCC1=CC(=C(O)C(=C1)OC(=O)CC(CC)CCC)OC(=O)CC(CC)CCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"5","A2","6b","Row74","5-A2-6b","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,8,"['Row61' 'Row253' 'Row349' 'Row445' 'Row540' 'Row636' 'Row732' 'Row828']",35,16,46.5,2.5,"Row75"
277,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","164.2 ¡¾ 5.7","0.13 ¡¾ 0.09","6.5 ¡¾ 0.9","85.1 ¡¾ 2.8","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 75)","C14PEG2K","9-A2-6b","DOPE","cholesterol","CCCCCCCC(CCCN)NCC1=CC(=C(O)C(=C1)OC(=O)CC(CC)CCC)OC(=O)CC(CC)CCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"9","A2","6b","Row75","9-A2-6b","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,8,"['Row121' 'Row254' 'Row350' 'Row446' 'Row541' 'Row637' 'Row733' 'Row829']",35,16,46.5,2.5,"Row91"
278,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","143.6 ¡¾ 8.7","0.09 ¡¾ 0.08","3.3 ¡¾ 3.8","85.3 ¡¾ 4.4","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 76)","C14PEG2K","6-A2-7","DOPE","cholesterol","CN(CCCC)NCC1=CC(=C(O)C(=C1)OC(=O)CCCCCCCC)OC(=O)CCCCCCCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"6","A2","7","Row76","6-A2-7","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,1,"['Row77']",35,16,46.5,2.5,"Row79"
279,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","195.5 ¡¾ 9.9","0.29 ¡¾ 0.07","'-9.7 ¡¾ 2.2","80.6 ¡¾ 2.9","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 77)","C14PEG2K","8-A2-7b","DOPE","cholesterol","CCCCCCCC(CCNCC1=CC(=C(O)C(=C1)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC)CC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"8","A2","7b","Row77","8-A2-7b","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,8,"['Row108' 'Row256' 'Row352' 'Row448' 'Row543' 'Row639' 'Row735' 'Row831']",35,16,46.5,2.5,"Row87"
280,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","179.2 ¡¾ 7.4","0.25 ¡¾ 0.09","5.8 ¡¾ 1.3","80.6 ¡¾ 3.1","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 78)","C14PEG2K","8-A2-7b2","DOPE","cholesterol","CCCCCCCC(CCNCC1=CC(=C(O)C(=C1)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC)CC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"8","A2","7b2","Row78","8-A2-7b2","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,8,"['Row109' 'Row257' 'Row353' 'Row449' 'Row544' 'Row640' 'Row736' 'Row832']",35,16,46.5,2.5,"Row88"
281,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","181.7 ¡¾ 4.9","0.24 ¡¾ 0.05","1.4 ¡¾ 0.6","83.1 ¡¾ 3.0","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 79)","C14PEG2K","5-A2-8b","DOPE","cholesterol","CN(C)CCNCC1=CC(=C(O)C(=C1)OC(=O)CC(CC)CCCCC)OC(=O)CC(CC)CCCCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"5","A2","8b","Row79","5-A2-8b","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,8,"['Row66' 'Row258' 'Row354' 'Row450' 'Row545' 'Row641' 'Row737' 'Row833']",35,16,46.5,2.5,"Row76"
282,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","141.6 ¡¾ 11.1","0.21 ¡¾ 0.04","3.9 ¡¾ 2.1","82.4 ¡¾ 3.3","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 80)","C14PEG2K","6-A2-8b","DOPE","cholesterol","CN(CCCC)NCC1=CC(=C(O)C(=C1)OC(=O)CC(CC)CCCCC)OC(=O)CC(CC)CCCCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"6","A2","8b","Row80","6-A2-8b","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,8,"['Row81' 'Row259' 'Row355' 'Row451' 'Row546' 'Row642' 'Row738' 'Row834']",35,16,46.5,2.5,"Row80"
283,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","171.4 ¡¾ 4.5","0.16 ¡¾ 0.04","6.7 ¡¾ 2.0","78.5 ¡¾ 4.5","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 81)","C14PEG2K","7-A2-8b","DOPE","cholesterol","CCCCCN(CCC)NCC1=CC(=C(O)C(=C1)OC(=O)CC(CC)CCCCC)OC(=O)CC(CC)CCCCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"7","A2","8b","Row81","7-A2-8b","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,8,"['Row96' 'Row260' 'Row356' 'Row452' 'Row547' 'Row643' 'Row739' 'Row835']",35,16,46.5,2.5,"Row83"
284,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","155.0 ¡¾ 6.5","0.15 ¡¾ 0.05","1.5 ¡¾ 0.7","79.7 ¡¾ 3.5","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 82)","C14PEG2K","8-A2-8b","DOPE","cholesterol","CCCCCCCC(CCNCC1=CC(=C(O)C(=C1)OC(=O)CC(CC)CCCCC)OC(=O)CC(CC)CCCCC)CC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"8","A2","8b","Row82","8-A2-8b","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,8,"['Row111' 'Row261' 'Row357' 'Row453' 'Row548' 'Row644' 'Row740' 'Row836']",35,16,46.5,2.5,"Row89"
285,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","156.3 ¡¾ 5.1","0.26 ¡¾ 0.11","6.3 ¡¾ 0.9","82.4 ¡¾ 3.3","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 83)","C14PEG2K","9-A2-8b","DOPE","cholesterol","CCCCCCCC(CCCN)NCC1=CC(=C(O)C(=C1)OC(=O)CC(CC)CCCCC)OC(=O)CC(CC)CCCCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"9","A2","8b","Row83","9-A2-8b","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,8,"['Row126' 'Row262' 'Row358' 'Row454' 'Row549' 'Row645' 'Row741' 'Row837']",35,16,46.5,2.5,"Row92"
286,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","190.5 ¡¾ 4.3","0.30 ¡¾ 0.12","4.3 ¡¾ 3.7","83.4 ¡¾ 3.1","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 84)","C14PEG2K","10-A2-8b","DOPE","cholesterol","NCCCCCCCCCCNCC1=CC(=C(O)C(=C1)OC(=O)CC(CC)CCCCC)OC(=O)CC(CC)CCCCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"10","A2","8b","Row84","10-A2-8b","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,1,"['Row141']",35,16,46.5,2.5,"Row13"
287,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","191.3 ¡¾ 3.4","0.16 ¡¾ 0.10","4.8 ¡¾ 2.2","84.4 ¡¾ 3.6","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 85)","C14PEG2K","9-A2-9","DOPE","cholesterol",,"CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"9","A2","9","Row85","9-A2-9","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,1,"['Row127']",35,16,46.5,2.5,"Row93"
288,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","190.4 ¡¾ 4.1","0.23 ¡¾ 0.08","'-1.8 ¡¾ 0.8","84.2 ¡¾ 2.9","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 86)","C14PEG2K","6-A3-6b","DOPE","cholesterol","CN(CCCC)NCC1=CC(=C(OC(=O)CC(CC)CCC)C(=C1)OC(=O)CC(CC)CCC)OC(=O)CC(CC)CCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"6","A3","6b","Row86","6-A3-6b","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,8,"['Row85' 'Row265' 'Row361' 'Row457' 'Row552' 'Row648' 'Row744' 'Row840']",35,16,46.5,2.5,"Row81"
289,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","204.3 ¡¾ 5.3","0.16 ¡¾ 0.07","'-6.4 ¡¾ 0.6","81.8 ¡¾ 4.7","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 87)","C14PEG2K","10-A3-6b","DOPE","cholesterol","NCCCCCCCCCCNCC1=CC(=C(OC(=O)CC(CC)CCC)C(=C1)OC(=O)CC(CC)CCC)OC(=O)CC(CC)CCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"10","A3","6b","Row87","10-A3-6b","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,1,"['Row145']",35,16,46.5,2.5,"Row14"
290,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","169.6 ¡¾ 4.5","0.19 ¡¾ 0.12","12.8 ¡¾ 0.7","86.8 ¡¾ 1.9","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 88)","C14PEG2K","7-A3-7b","DOPE","cholesterol","CCCCCN(CCC)NCC1=CC(=C(OC(=O)CC(CC)CCCC)C(=C1)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"7","A3","7b","Row88","7-A3-7b","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,8,"['Row101' 'Row267' 'Row363' 'Row459' 'Row554' 'Row650' 'Row746' 'Row842']",35,16,46.5,2.5,"Row84"
291,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","201.5 ¡¾ 4.4","0.24 ¡¾ 0.06","2.3 ¡¾ 0.9","82.4 ¡¾ 3.3","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 89)","C14PEG2K","9-A3-7b","DOPE","cholesterol","CCCCCCCC(CCCN)NCC1=CC(=C(OC(=O)CC(CC)CCCC)C(=C1)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"9","A3","7b","Row89","9-A3-7b","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,1,"['Row131']",35,16,46.5,2.5,"Row94"
292,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","162.3 ¡¾ 4.1","0.22 ¡¾ 0.06","'-1.7 ¡¾ 0.6","83.2 ¡¾ 4.1","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 90)","C14PEG2K","6-A3-7b2","DOPE","cholesterol","CN(CCCC)NCC1=CC(=C(OC(=O)CC(CC)CCCC)C(=C1)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"6","A3","7b2","Row90","6-A3-7b2","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,8,"['Row87' 'Row269' 'Row365' 'Row461' 'Row556' 'Row652' 'Row748' 'Row844']",35,16,46.5,2.5,"Row82"
293,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","143.2 ¡¾ 6.9","0.27 ¡¾ 0.11","1.5 ¡¾ 2.6","75.9 ¡¾ 5.4","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 91)","C14PEG2K","8-A3-7b2","DOPE","cholesterol","CCCCCCCC(CCNCC1=CC(=C(OC(=O)CC(CC)CCCC)C(=C1)OC(=O)CC(CC)CCCC)OC(=O)CC(CC)CCCC)CC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"8","A3","7b2","Row91","8-A3-7b2","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,8,"['Row117' 'Row270' 'Row366' 'Row462' 'Row557' 'Row653' 'Row749' 'Row845']",35,16,46.5,2.5,"Row90"
294,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","126.7 ¡¾ 5.9","0.21 ¡¾ 0.09","'-1.2 ¡¾ 2.7","85.5 ¡¾ 4.5","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 92)","C14PEG2K","5-A3-8b","DOPE","cholesterol","CN(C)CCNCC1=CC(=C(OC(=O)CC(CC)CCCCC)C(=C1)OC(=O)CC(CC)CCCCC)OC(=O)CC(CC)CCCCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"5","A3","8b","Row92","5-A3-8b","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,7,"['Row73' 'Row271' 'Row367' 'Row558' 'Row654' 'Row750' 'Row846']",35,16,46.5,2.5,"Row77"
295,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","113.9 ¡¾ 5.0","0.13 ¡¾ 0.05","'-3.1 ¡¾ 2.1","73.8 ¡¾ 4.0","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 93)","C14PEG2K","7-A3-8b","DOPE","cholesterol","CCCCCN(CCC)NCC1=CC(=C(OC(=O)CC(CC)CCCCC)C(=C1)OC(=O)CC(CC)CCCCC)OC(=O)CC(CC)CCCCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"7","A3","8b","Row93","7-A3-8b","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,8,"['Row103' 'Row272' 'Row368' 'Row463' 'Row559' 'Row655' 'Row751' 'Row847']",35,16,46.5,2.5,"Row85"
296,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","115.4 ¡¾ 7.1","0.16 ¡¾ 0.08","6.7 ¡¾ 4.5","75.1 ¡¾ 2.6","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 94)","C14PEG2K","5-A3-9b2","DOPE","cholesterol","CN(C)CCNCC1=CC(=C(OC(=O)CCC(CC)CCCCCC)C(=C1)OC(=O)CCC(CC)CCCCCC)OC(=O)CCC(CC)CCCCCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"5","A3","9b2","Row94","5-A3-9b2","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,8,"['Row74' 'Row273' 'Row369' 'Row464' 'Row560' 'Row656' 'Row752' 'Row848']",35,16,46.5,2.5,"Row78"
297,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","109.2 ¡¾ 5.2","0.25 ¡¾ 0.05","'-3.0 ¡¾ 4.1","80.4 ¡¾ 4.3","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 95)","C14PEG2K","7-A3-9b2","DOPE","cholesterol","CCCCCN(CCC)NCC1=CC(=C(OC(=O)CCC(CC)CCCCCC)C(=C1)OC(=O)CCC(CC)CCCCCC)OC(=O)CCC(CC)CCCCCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; gene_expression_result: Liver-enriched delivery; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"7","A3","9b2","Row95","7-A3-9b2","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,8,"['Row104' 'Row274' 'Row370' 'Row465' 'Row561' 'Row657' 'Row753' 'Row849']",35,16,46.5,2.5,"Row86"
298,"Custom lipid","PEG2000","cholesterol","DOPE","35:2.5:46.5:16","114.1 ¡¾ 6.7","0.16 ¡¾ 0.04","2.1 ¡¾ 1.6","84.9 ¡¾ 4.8","OTHER:b-DNA:FLuc mRNA weight ratio 10:1","mRNA","firefly_luciferase, barcode(dna barcode 96)","C14PEG2K","10-A3-9b2","DOPE","cholesterol","NCCCCCCCCCCNCC1=CC(=C(OC(=O)CCC(CC)CCCCCC)C(=C1)OC(=O)CCC(CC)CCCCCC)OC(=O)CCC(CC)CCCCCC","CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing or pipette mixing; device_used: Microfluidic device with staggered herringbone features; total_flow_rate_ml_min: 2.4; flow_rate_ratio: 1:3 (organic:aqueous); aqueous_phase_composition: 10 mM citrate buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: Room temperature; post_processing: Dialysis in 1x PBS for 2h, filtration through 0.45 ¥ìm filter; sterilization: 0.45 ¥ìm filtration; storage_buffer: 1x PBS","cell_line: HeLa; animal_model: C57BL/6J female mice; administration_route: intravenous (IV); dose: 1.0 mg/kg total nucleic acid; biodistribution_result: Measured by deep sequencing in heart, liver, spleen, lungs, kidneys; toxicity_profile: Cell viability >85%","High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","['Lulu Xue', 'Alex G. Hamilton', 'Gan Zhao', 'Zebin Xiao', 'Rakan El-Mayta', 'Xuexiang Han', 'Ningqiang Gong', 'Xinhong Xiong', 'Junchao Xu', 'Christian G. Figueroa-Espada', 'Sarah J. Shepherd', 'Alvin J. Mukalel', 'Mohamad-Gabriel Alameh', 'Jiaxi Cui', 'Karin Wang', 'Andrew E. Vaughan', 'Drew Weissman', 'Michael J. Mitchell']","https://doi.org/10.1038/s41467-024-45422-9","Nature Communications",2024,"10","A3","9b2","Row96","10-A3-9b2","DOPE","cholesterol","PEG2000","35:2.5:46.5:16","IL:PEG:CHL:HL",1,1,"['Row149']",35,16,46.5,2.5,"Row15"
